The role of cell-free DNA in fibrinolysis for intraventricular hemorrhage

被引:6
|
作者
Xie, Fangke [1 ]
Tan, Qiang [2 ]
Yu, Anyong [1 ]
Guo, Peiwen [2 ]
Wang, Ling [2 ]
Zeng, Zongwei [2 ]
Liang, Liang [2 ]
Xian, Jishu [2 ]
Feng, Hua [2 ]
Chen, Zhi [2 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Peoples R China
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
intraventricular hemorrhage; tissue plasminogen activator; neutrophil extracellular traps; cell-free DNA; fibrinolysis; vascular disorders; NEUTROPHIL EXTRACELLULAR TRAPS; TISSUE-PLASMINOGEN ACTIVATOR; CITRULLINATED HISTONE H3; CANINE MODEL; BLOOD-CLOT; UROKINASE; HEMATOMA; LYSIS; THERAPY;
D O I
10.3171/2020.7.JNS201429
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Tissue plasminogen activator (tPA) fibrinolysis did not improve functional outcomes of patients with intraventricular hemorrhage (IVH), largely because of the unsatisfactory clot clearance. The presence of neutrophil extracellular traps (NETs) within the clot has been confirmed to impair tPA fibrinolysis, but the mechanism has been unclear. The authors hypothesized that cell-free DNA (cfDNA), the main framework of NETs, might be the important reason for the fibrinolysis resistance, and they validated the hypothesis, hoping to provide a new target to promote intraventricular fibrinolysis. METHODS First, cfDNA was detected in IVH clots by immunofluorescence staining in a rat model of IVH. Second, after blood (with or without exogenous cfDNA) intraventricular injection, IVH rats were given intraventricular infusion of 2 mu l of saline, tPA, or tPA + DNase1 randomly. Then, the ventricular volume, animal behavior, and reactive astrocyte proliferation were assessed. Third, the IVH clots were collected for fibrinolysis assay in vitro. Finally, the effects of exogenous cfDNA in IVH were evaluated. RESULTS The presence of cfDNA in clots was observed as early as 1 hour after IVH. Compared with the whole-blood model, blood + cfDNA caused more severe ventricular dilation (day 7: blood 32.47 +/- 2.096 mm(3) vs blood + DNA 40.09 +/- 2.787 mm(3), p < 0.05), increased fibrinolysis resistance to tPA (day 7: tPA + DNA 26.04 +/- 1.318 mm(3) vs tPA 22.15 +/- 1.706 mm(3), p < 0.05), and further deteriorated the functional defects in rats (blood vs blood + DNA, p < 0.05). Degradation of cfDNA by DNase1 further enhanced the fibrinolysis effects on relieving the ventricular dilation (day 7: tPA + DNase1 11.67 +/- 2.023 mm(3) vs tPA, p < 0.05), improving the functional outcome (tPA vs tPA + DNase1, p < 0.05) and reducing periventricular astrocyte proliferation. CONCLUSIONS cfDNA impaired tPA fibrinolysis for IVH, and degradation of cfDNA may be a new target to improve this condition.
引用
收藏
页码:1105 / 1112
页数:8
相关论文
共 50 条
  • [41] Immunoregulatory effect and the role of plasma cell-free DNA in celiac disease
    Zinkova, A.
    Brynychova, I.
    Hoffmanova, I.
    Korabecna, M.
    Dankova, P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1361 - 1362
  • [42] THE ROLE OF CELL-FREE DNA IN THE PATHOGENESIS OF ACUTE AND CHRONIC LIVER DISEASE
    Gromova, Barbora
    Konecna, Barbora
    Vasekova, Michaela
    Kupcova, Viera
    Celec, Peter
    Gardlik, Roman
    GASTROENTEROLOGY, 2023, 164 (06) : S1313 - S1313
  • [43] The Role of Cell-Free Plasma DNA in Peritoneal Dialysis Patients with Peritonitis
    Virzi, Grazia Maria
    Manani, Sabrina Milan
    Cantaluppi, Vincenzo
    Brocca, Alessandra
    de Cal, Massimo
    Tantillo, Ilaria
    Mason, Giacomo
    Ramponi, Francesco
    Berti, Sonia
    Crepaldi, Carlo
    Clementi, Maurizio
    Ronco, Claudio
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (07): : 755 - U119
  • [44] The role of circulating cell-free DNA as an inflammatory mediator after stroke
    Roth, Stefan
    Wernsdorf, Saskia R. R.
    Liesz, Arthur
    SEMINARS IN IMMUNOPATHOLOGY, 2023, 45 (03) : 411 - 425
  • [45] The role of ultrasound in women who undergo cell-free DNA screening
    Norton, Mary E.
    Biggio, Joseph R.
    Kuller, Jeffrey A.
    Blackwell, Sean C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (03) : B2 - B7
  • [46] The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis
    Clementi, Anna
    Virzi, Grazia Maria
    Brocca, Alessandra
    Pastori, Silvia
    de Cal, Massimo
    Marcante, Stefano
    Granata, Antonio
    Ronco, Claudio
    BLOOD PURIFICATION, 2016, 41 (1-3) : 34 - 40
  • [47] The role and diagnostic value of cell-free DNA in systemic lupus erythematosus
    Truszewska, A.
    Foroncewicz, B.
    Paczek, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : 330 - 336
  • [48] The emerging role of cell-free DNA as a molecular marker for duodenal adenocarcinoma
    Lai, Hon-Fan
    Wang, Shin-E
    Chen, Shih-Chin
    Shyr, Bor-Shiuan
    Shyr, Yi-Ming
    Shyr, Bor-Uei
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (04) : 422 - 427
  • [49] The role of cell-free DNA size distribution in the management of prostate cancer
    Boddy, Jane L.
    Gal, Shira
    Malone, Peter R.
    Shaida, Nadeem
    Wainscoat, James S.
    Harris, Adrian L.
    ONCOLOGY RESEARCH, 2006, 16 (01) : 35 - 41
  • [50] The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer
    Ellinger, Joerg
    Mueller, Stefan C.
    Stadler, Thomas C.
    Jung, Andreas
    von Ruecker, Alexander
    Bastian, Patrick J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (02) : 124 - 129